-+ 0.00%
-+ 0.00%
-+ 0.00%

Recently, Shandong Xinhang Line Biotechnology Co., Ltd. announced the completion of Series A financing of tens of millions of yuan. This round of financing was led by CMB International Capital, followed by Yida Capital, and Dianshi Capital acted as the exclusive financial advisor for this round of financing. This round of financing will mainly be used to upgrade the drug-resistant bacteriophage bank and expand overseas business.

Zhitongcaijing·07/27/2026 01:25:06
Listen to the news
Recently, Shandong Xinhang Line Biotechnology Co., Ltd. announced the completion of Series A financing of tens of millions of yuan. This round of financing was led by CMB International Capital, followed by Yida Capital, and Dianshi Capital acted as the exclusive financial advisor for this round of financing. This round of financing will mainly be used to upgrade the drug-resistant bacteriophage bank and expand overseas business.